RFK Jr.'s new ACIP to discuss flu shots, MMRV vaccine

Next week, the public will get its first look at how RFK Jr.'s new panel will weigh evidence on vaccines.

June 18, 2025 Check out STAT+

Sponsored By

Joe Raedle/Getty Images) STAT+ | Vaccine advisers to consider MMRV vaccines, 'thimerosal containing' flu shots in pared-down meeting The meeting will give the public its first look at how Kennedy's new ACIP panel will weigh the evidence for vaccines. By Chelsea Cirruzzo HIV protection with just two shots a year: FDA approves Gilead drug Gilead's PrEP drug lenacapavir, to marketed under the name Yeztugo, provides six months protection from HIV with a single shot. By Jason Mast and Ed Silverman STAT+ | Vinay Prasad named chief medical and science officer at FDA Vinay Prasad is taking on top roles at the FDA, solidifying his position as a top advisor to Commissioner Marty Makary. By Lizzy Lawrence Adobe STAT+ | Psychedelics proponents hope Trump administration will foster a new era RFK Jr. and Trump allies push for psychedelics to treat PTSD and depression. FDA in position to greenlight MDMA and psilocybin for mental health treatment. By Olivia Goldhill and Meghana Keshavan Supreme Court ruling on gender-affirming care delivers major setback for transgender rights Supreme Court, in U.S. v. Skrmetti, upholds Tennessee ban on gender-affirming care for minors, sets precedent for more than states with similar laws. By Theresa Gaffney STAT+ | Does the FDA commissioner's new voucher program open a Pandora's box? The notion of faster drug reviews makes sense, but the "Commissioner's National Priority Voucher" program also threatens to come at a cost. By Matthew Herper Adobe Opinion: Following second patient death, Duchenne muscular dystrophy families deserve answers about Elevidys Gene therapy holds promise for treating Duchenne muscular dystrophy. But after a second Elevidys death, the system must work better. By Christine McSherry Opinion: Thousands, including my husband, died because of tainted blood. I'm afraid it could happen again The Trump administration's reckless slashing makes me worry we will be underprepared if a new virus or pathogen enters our blood supply. By Kathy Seward MacKay Research funding has unexpected benefits. A lizard study led to Ozempic STAT Video: With the future of NIH funding in jeopardy, Reed Jobs tells us how studying a lizard brought the world a blockbuster drug — Ozempic. By Alex Hogan

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser